Risk Factors of (131)I-Induced Salivary Gland Damage in Thyroid Cancer Patients

CONTEXT: Sialadenitis and xerostomia are major adverse effects of (131)I therapy in thyroid cancer patients. The risk factors for these adverse effects, other than administered activity of (131)I, have not been investigated. OBJECTIVE: The aim of this study is to identify risk factors for (131)I-ind...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Hollingsworth, Brynn, Senter, Leigha, Zhang, Xiaoli, Brock, Guy N., Jarjour, Wael, Nagy, Rebecca, Brock, Pamela, Coombes, Kevin R., Kloos, Richard T., Ringel, Matthew D., Sipos, Jennifer, Lattimer, Ilene, Carrau, Ricardo, Jhiang, Sissy M.
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5095242/
https://ncbi.nlm.nih.gov/pubmed/27533304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2016-1605
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados